BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35367071)

  • 1. Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages.
    Vandoorn E; Parys A; Chepkwony S; Chiers K; Van Reeth K
    Vaccine; 2022 Apr; 40(19):2723-2732. PubMed ID: 35367071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bivalent live attenuated influenza virus vaccine protects against H1N2 and H3N2 viral infection in swine.
    Landreth S; Detmer S; Gerdts V; Zhou Y
    Vet Microbiol; 2021 Feb; 253():108968. PubMed ID: 33418392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
    Vandoorn E; Stadejek W; Parys A; Chepkwony S; Chiers K; Van Reeth K
    J Virol; 2022 Jun; 96(11):e0051922. PubMed ID: 35546120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.
    Lee J; Li Y; Li Y; Cino-Ozuna AG; Duff M; Lang Y; Ma J; Sunwoo S; Richt JA; Ma W
    Vaccine; 2021 Apr; 39(14):1943-1950. PubMed ID: 33715905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.
    Vincent AL; Ma W; Lager KM; Richt JA; Janke BH; Sandbulte MR; Gauger PC; Loving CL; Webby RJ; García-Sastre A
    J Virol; 2012 Oct; 86(19):10597-605. PubMed ID: 22811541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
    Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
    Vincent AL; Ma W; Lager KM; Janke BH; Webby RJ; García-Sastre A; Richt JA
    Vaccine; 2007 Nov; 25(47):7999-8009. PubMed ID: 17933442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model.
    Chepkwony S; Parys A; Vandoorn E; Chiers K; Van Reeth K
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32882956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bivalent Live Attenuated Influenza Virus Vaccine Protects against Drifted H1N2 and H3N2 Clinical Isolates in Swine.
    Aubrey L; Barron-Castillo U; Detmer S; Zhou Y
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.
    Loving CL; Lager KM; Vincent AL; Brockmeier SL; Gauger PC; Anderson TK; Kitikoon P; Perez DR; Kehrli ME
    J Virol; 2013 Sep; 87(17):9895-903. PubMed ID: 23824815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternating 3 different influenza vaccines for swine in Europe for a broader antibody response and protection.
    Parys A; Vandoorn E; Chiers K; Van Reeth K
    Vet Res; 2022 Jun; 53(1):44. PubMed ID: 35705993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs.
    Kappes MA; Sandbulte MR; Platt R; Wang C; Lager KM; Henningson JN; Lorusso A; Vincent AL; Loving CL; Roth JA; Kehrli ME
    Vaccine; 2012 Jan; 30(2):280-8. PubMed ID: 22067263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent immune responses and disease outcomes in piglets immunized with inactivated and attenuated H3N2 swine influenza vaccines in the presence of maternally-derived antibodies.
    Sandbulte MR; Platt R; Roth JA; Henningson JN; Gibson KA; Rajão DS; Loving CL; Vincent AL
    Virology; 2014 Sep; 464-465():45-54. PubMed ID: 25043588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A virus shedding reduction observed at 12 weeks post-vaccination when newborn pigs are administered live-attenuated influenza virus vaccine.
    Kaiser TJ; Smiley RA; Fergen B; Eichmeyer M; Genzow M
    Influenza Other Respir Viruses; 2019 May; 13(3):274-278. PubMed ID: 30843324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs.
    Li C; Culhane MR; Cheeran M; Galina Pantoja L; Jansen ML; Amodie D; Mellencamp MA; Torremorell M
    Vet Res; 2020 Jul; 51(1):89. PubMed ID: 32646490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs.
    Renu S; Feliciano-Ruiz N; Patil V; Schrock J; Han Y; Ramesh A; Dhakal S; Hanson J; Krakowka S; Renukaradhya GJ
    Front Immunol; 2021; 12():584299. PubMed ID: 33746943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-attenuated influenza virus elicits broad protection against challenge viruses with different serotypes in swine.
    Mamerow S; Scheffter R; Röhrs S; Stech O; Blohm U; Schwaiger T; Schröder C; Ulrich R; Schinköthe J; Beer M; Mettenleiter TC; Stech J
    Vet Microbiol; 2019 Apr; 231():160-168. PubMed ID: 30955804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.